Glenmark Pharmaceuticals is planning to set up a new manufacturing
facility spread over 100,000 square feet at Monroe Corporate Center,
North Carolina, USA. The company informed that they will first begin
work on an oral solid unit and thereafter set up manufacturing units for
injectables.
With the setting up of a new facility in the US, the company would would further enhance their manufacturing footprint making it truly global in every sense of The company expects to start manufacturing activity by the end of the current financial year FY 2014 – 15, he added. It is understood that the this facility is dedicated only for the US market and is Glenmark’s first manufacturing facility in North America adding to its list of 14 plants in four countries – India, Brazil, Argentina and Czech Republic
With the setting up of a new facility in the US, the company would would further enhance their manufacturing footprint making it truly global in every sense of The company expects to start manufacturing activity by the end of the current financial year FY 2014 – 15, he added. It is understood that the this facility is dedicated only for the US market and is Glenmark’s first manufacturing facility in North America adding to its list of 14 plants in four countries – India, Brazil, Argentina and Czech Republic
No comments:
Post a Comment